Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Richard A. Petruschke"'
Publikováno v:
The American Journal of Geriatric Pharmacotherapy. 10:47-60
Nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with a dose-related risk of cardiovascular, renal, and gastrointestinal adverse events (AEs). Topical NSAIDs produce lower systemic NSAID exposure compared with oral NSAIDs, offering potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a386891416b1acca87d3deac8f43a2d
https://doi.org/10.1016/j.amjopharm.2011.12.002
https://doi.org/10.1016/j.amjopharm.2011.12.002
Autor:
Christine Mullen, Anne E. de Papp, Christine Simonelli, Frank L. Lanza, Erluo Chen, E. Michael Lewiecki, Byron Cryer, Neil Binkley, Richard A. Petruschke
Publikováno v:
The American Journal of Geriatric Pharmacotherapy. 3:127-136
Objective: This study evaluated the overall safety and tolerability of once-weekly (OW) alendronate 70 mg oral solution (OS) versus OW placebo OS. Methods: Postmenopausal, osteoporotic women were enrolled at 51 centers in the United States in a 6-mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd46171776d34c82d91c0dfed0272726
https://doi.org/10.1016/s1543-5946(05)80019-4
https://doi.org/10.1016/s1543-5946(05)80019-4
Publikováno v:
Alimentary Pharmacology and Therapeutics. 21:599-607
Summary Background : Both oral bisphosphonates and non-steroidal anti-inflammatory drugs have the potential to irritate the upper gastrointestinal mucosa, and are frequently used by the same patient population. Aim : To determine the rate of upper ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bfaeb1912e5154457fa5e96446fb509
https://doi.org/10.1111/j.1365-2036.2005.02378.x
https://doi.org/10.1111/j.1365-2036.2005.02378.x
Autor:
Tara A. Erb, Gregory A. Winchell, Murray A. Abramson, Jonathan M. Edelman, Frank S. Rhame, Sandy L. Rawlins, Richard A. Petruschke, Helene M. Wilson
Publikováno v:
Antimicrobial Agents and Chemotherapy. 48:4200-4208
Single-protease inhibitor regimens significantly reduced the morbidity and mortality associated with human immunodeficiency virus (HIV) following their introduction (19, 20). More recently, boosted protease inhibitor regimens combined ritonavir (RTV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da63dd1a5e467c8113337c184db1b814
https://doi.org/10.1128/aac.48.11.4200-4208.2004
https://doi.org/10.1128/aac.48.11.4200-4208.2004
Autor:
Sydney Lou Bonnick, Paul Miller, Michael R. McClung, Desmond E. Thompson, Richard A. Petruschke, Susan B. Broy, Anne E. de Papp, Clifford J. Rosen, Erluo Chen, Risa Kagan, Marc C. Hochberg
Publikováno v:
Journal of Bone and Mineral Research. 20:141-151
Once-weekly alendronate 70 mg and once-weekly risedronate 35 mg are indicated for the treatment of postmenopausal osteoporosis. These two agents were compared in a 12-month head-to-head trial. Greater gains in BMD and greater reductions in markers of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc4a144227dd96e6f979e9a107c4a1e
https://doi.org/10.1359/jbmr.040920
https://doi.org/10.1359/jbmr.040920
Autor:
Brian Fitzgerald, Richard A. Petruschke, David J. Chang, Steven R. Bird, Andrew M. Tershakovec, Paul J. Desjardins, Peter McL. Black, Steven Daniels
Publikováno v:
Current Medical Research and Opinion. 20:1523-1537
The relative efficacy of rofecoxib, diclofenac sodium, and placebo were compared in the treatment of acute pain after bunionectomy surgery.This was a double-blind, randomized, two-part study of 252 patients with moderate-to-severe pain the day after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8714c310b0304524835753f917e4b92
https://doi.org/10.1185/030079904x3069
https://doi.org/10.1185/030079904x3069
Autor:
Richard A. Petruschke, Steven R. Bird, David J. Chang, Erluo Chen, Peter McL. Black, Gregory P. Geba, Paul J. Desjardins
Publikováno v:
Current Medical Research and Opinion. 20:939-949
To compare the efficacy of a single dose of rofecoxib 50 mg with a single dose of oxycodone/acetaminophen 10/650 mg over 6 h as well as with a multidose regimen of oxycodone/acetaminophen 10/650 mg followed by oxycodone/acetaminophen 5/325 mg over 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92534dabd9daf2f48f39f693ee98bb1
https://doi.org/10.1185/030079904125003863
https://doi.org/10.1185/030079904125003863
Autor:
Jerry Green, Richard A. Petruschke, Robert A. Moidel, Alan K. Matsumoto, Daryl K. Najarian, Alan Kivitz, Mary E. Dixon, Stanley Cohen, Adam B. Polis, Gregory P. Geba, Herbert S. B. Baraf, Maria Greenwald
Publikováno v:
Journal of the American Geriatrics Society. 52:666-674
To evaluate the use of starting doses of rofecoxib and nabumetone in patients with osteoarthritis (OA) of the knee.A 6-week, randomized, parallel-group, double-blind, placebo-controlled study.One hundred thirteen outpatient sites in the United States
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3052b08eba1ecfb59a1add5d97c80067
https://doi.org/10.1111/j.1532-5415.2004.52201.x
https://doi.org/10.1111/j.1532-5415.2004.52201.x
Autor:
Daryl K. Najarian, Gregory P. Geba, John Londoño, Bernard R. Rubin, Zafer E. Ozturk, Sandra V. Navarra, Richard A. Petruschke, Keith G. Pryhuber, Robert Burton, Joseph Antigua, Erluo Chen, Margaret Lund
Publikováno v:
Arthritis & Rheumatism. 50:598-606
Objective To evaluate the efficacy and safety of etoricoxib and indomethacin in the treatment of patients with acute gout. Methods A randomized, double-blind, active-comparator study was conducted at 42 sites. A total of 189 men and women (≥18 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::914306365752745fe0f71564a738788f
https://doi.org/10.1002/art.20007
https://doi.org/10.1002/art.20007
Autor:
Dieter Felsenberg, Jorge Cannata Andia, Laurent Benhamou, Richard A. Petruschke, Luna Zaru, Andrea Rybak-Feglin, Jean-Yves Reginster, Silvano Adami, David J. Hosking, Matti Välimäki, Arthur C. Santora, Carol Yacik
Publikováno v:
Current Medical Research and Opinion. 19:383-394
To compare the effects of alendronate (ALN) 70 mg once weekly (OW) and risedronate (RIS) 5 mg daily between-meal dosing on biochemical markers of bone turnover and bone mineral density (BMD) in postmenopausal women with osteoporosis.This was a 3-mont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e786cf2ddd51d0ddf30c22a1c17dd0ab
https://doi.org/10.1185/030079903125002009
https://doi.org/10.1185/030079903125002009